Zogenix Inc. (ZGNX)

47.95
0.05 0.10
NASDAQ : Health Technology
Prev Close 47.90
Open 47.74
Day Low/High 46.95 / 48.09
52 Wk Low/High 33.43 / 59.85
Volume 413.20K
Avg Volume 547.40K
Exchange NASDAQ
Shares Outstanding 42.41M
Market Cap 2.02B
EPS -3.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ZGNX NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Investigation Of Securities Claims Against Zogenix, Inc. Investors With Losses In Excess Of $100K Are Encouraged To Contact The Firm - ZGNX

ZGNX NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Investigation Of Securities Claims Against Zogenix, Inc. Investors With Losses In Excess Of $100K Are Encouraged To Contact The Firm - ZGNX

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Zogenix, Inc.

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors Who Suffered Large Investment Losses To Contact The Firm

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors Who Suffered Large Investment Losses To Contact The Firm

SAN DIEGO, June 1, 2019 /PRNewswire/ -- Johnson Fistel, LLP announces that class action lawsuits have been commenced on behalf of shareholders of the publicly-traded companies listed below.

WeissLaw LLP Investigates Zogenix, Inc.

WeissLaw LLP Investigates Zogenix, Inc.

NEW YORK, May 31, 2019 /PRNewswire/ --  WeissLaw LLP, a national class action and shareholders' rights law firm, announces an investigation of Zogenix, Inc.

Notable Thursday Option Activity: ZGNX, DCPH, VREX

Notable Thursday Option Activity: ZGNX, DCPH, VREX

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zogenix Inc. , where a total of 13,927 contracts have traded so far, representing approximately 1.4 million underlying shares.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zogenix, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Zogenix, Inc. Of Class Action Lawsuit And Upcoming Deadline- ZGNX

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Zogenix, Inc. Of Class Action Lawsuit And Upcoming Deadline- ZGNX

NEW YORK, May 14, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zogenix, Inc.

Glancy Prongay & Murray Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Zogenix, Inc.

Glancy Prongay & Murray Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Zogenix, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming  June 11, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Zogenix, Inc.

ZGNX CLASS ACTION ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Zogenix, Inc. - ZGNX

ZGNX CLASS ACTION ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Zogenix, Inc. - ZGNX

NEW YORK, May 2, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Zogenix, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zogenix, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm

NEW YORK, April 22, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zogenix, Inc.

ZGNX CLASS ACTION ALERT: Rosen Law Firm Reminds Zogenix, Inc. Investors Of Important Deadline In Securities Class Action - ZGNX

ZGNX CLASS ACTION ALERT: Rosen Law Firm Reminds Zogenix, Inc. Investors Of Important Deadline In Securities Class Action - ZGNX

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zogenix, Inc.

Robbins Arroyo LLP: Zogenix, Inc. (ZGNX) Misled Shareholders According To A Recently Filed Lawsuit

Robbins Arroyo LLP: Zogenix, Inc. (ZGNX) Misled Shareholders According To A Recently Filed Lawsuit

Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of Zogenix, Inc.

Lifshitz & Miller LLP Announces Investigation Of Anadarko Petroleum Corporation, Duluth Holdings, Inc., Establishment Labs Holdings Inc., Flex Ltd., Global Brass And Copper Holdings, Inc., Indivior PLC, Papa Murphy's Holdings, Inc., And Zogenix, Inc.

Lifshitz & Miller LLP Announces Investigation Of Anadarko Petroleum Corporation, Duluth Holdings, Inc., Establishment Labs Holdings Inc., Flex Ltd., Global Brass And Copper Holdings, Inc., Indivior PLC, Papa Murphy's Holdings, Inc., And Zogenix, Inc.

NEW YORK, April 17, 2019 /PRNewswire/ -- Anadarko Petroleum Corporation (APC) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of Anadarko to Chevron Corporation.

ZGNX CLASS ACTION ALERT: Hagens Berman Alerts Zogenix (ZGNX) Investors To Securities Class Action, Encourages Investors To Contact The Firm

ZGNX CLASS ACTION ALERT: Hagens Berman Alerts Zogenix (ZGNX) Investors To Securities Class Action, Encourages Investors To Contact The Firm

SAN FRANCISCO, April 16, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Zogenix, Inc. - ZGNX

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Zogenix, Inc. - ZGNX

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Zogenix, Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against Zogenix, Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against Zogenix, Inc.

Federman & Sherwood announces that on April 12, 2019, a class action lawsuit was filed in the United States District Court for the Northern District of California against Zogenix, Inc.

Hagens Berman Alerts Zogenix (ZGNX) Investors Of The Firm's Investigation Of Possible Securities Law Violations, Encourages Investors To Contact The Firm

Hagens Berman Alerts Zogenix (ZGNX) Investors Of The Firm's Investigation Of Possible Securities Law Violations, Encourages Investors To Contact The Firm

SAN FRANCISCO, April 15, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc.

Investor Alert: Kaplan Fox Investigates Zogenix, Inc.

Investor Alert: Kaplan Fox Investigates Zogenix, Inc.

NEW YORK, April 15, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.

Former California Deputy Attorney General And Special Counsel With Johnson Fistel Launches Investigation Into Zogenix, Inc. (ZGNX)

Former California Deputy Attorney General And Special Counsel With Johnson Fistel Launches Investigation Into Zogenix, Inc. (ZGNX)

SAN DIEGO, April 13, 2019 /PRNewswire/ -- Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq.

Aerie and Inovio Among Pharma Stocks Offering High Risk and Even Higher Upside

Aerie and Inovio Among Pharma Stocks Offering High Risk and Even Higher Upside

Risk and reward are the yin and yang of investing, and are closely related, especially in the pharmaceutical field.

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of Zogenix, Inc. Investors (ZGNX)

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of Zogenix, Inc. Investors (ZGNX)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Zogenix, Inc.

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of Zogenix, Inc. Investors (ZGNX)

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of Zogenix, Inc. Investors (ZGNX)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Zogenix, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Zogenix, Inc. - ZGNX

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Zogenix, Inc. - ZGNX

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Zogenix, Inc.

You Don't Have to Swing for the Fences With Every Investment in Small Caps

You Don't Have to Swing for the Fences With Every Investment in Small Caps

The way I do that is by using buy-write option strategies.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Zogenix, Inc. - ZGNX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Zogenix, Inc. - ZGNX

NEW YORK, April 9, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zogenix, Inc.

Zogenix Shares Plummet After FDA Rejection of Seizure Treatment

Zogenix Shares Plummet After FDA Rejection of Seizure Treatment

Shares of Zogenix plunge after the FDA rejects an initial marketing application for one of its more promising epilepsy treatment drugs.

The Best Approach to Trading Lyft

The Best Approach to Trading Lyft

Valuation and all the other issues that are being discussed are secondary to the price action.

What We are Seeing So Far Is Some Very Nervous Action

What We are Seeing So Far Is Some Very Nervous Action

The potential for a negative reaction to the Trump, Xi meeting is high.